
David Goeddel
QuietNamed in filings at The Column Group
- Board seats filed
- 12
all filings on record

Named in filings at The Column Group
all filings on record
last 24 months
from a verified or cited source
| NGM Bio Holdings | Biotech & pharma | July 2024 | None on file |
| Hexagon Bio | Biotech & pharma | June 2021 | Nextech Viii Carry Scsp |
| A2 Biotherapeutics | Biotech & pharma | September 2020 | Nextech Viii Carry Scsp, Vida Ventures |
| Surrozen | Biotech & pharma | June 2020 | None on file |
| Exonics Therapeutics | Not yet classified | November 2017 | None on file |
| RAPT Therapeutics | Biotech & pharma | April 2016 | Westlake Biopartners |
| NEURONA THERAPEUTICS | Biotech & pharma | December 2014 | None on file |
| NGM BIOPHARMACEUTICALS | Biotech & pharma | October 2014 | None on file |
| CONSTELLATION PHARMACEUTICALS | Biotech & pharma | August 2014 | Third Rock Ventures |
| IGENICA | Biotech & pharma | January 2014 | Caduceus Capital, Orbimed Asia Partners, Orbimed Genesis |
| Nurix | Biotech & pharma | December 2013 | None on file |
| Flexus Biosciences | Biotech & pharma | October 2013 | Westlake Biopartners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name David Goeddel on the board, based on 11 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.